This invention provides novel processes for therapeutic applications,
including the treatment of subjects carrying infectious agents or having
impaired autoimmunity or impaired immune condition. The therapeutic
applications disclosed herein are also directed at the treatment of
cancerous subjects with malignant tumors containing cancerous cells or
malignant or cancerous cells. Vaccination processes for preventing
infections in subjects are also provided. The novel processes comprise
introducing into or administering to a subject one or more antigens, or
trained or adopted immune cells. These antigens or immune cells are
capable of establishing or increasing at least one first specific immune
response and decreasing at least one second specific immune response.
Such responses include components, such as cellular immune reaction
elements, humoral immune reaction elements and cytokines, the latter also
encompassing interferons and lymphokines. Useful compositions are also
provided by this invention.